Ribozymes

5-Prime | Ribozymes 1. What's a ribozyme? It is a catalytic RNA molecule. That discovery won the 1989 Nobel Prize in Chemistry for Tom Cech and Sidney Altman. Eight classes of ribozymes have now been identified, including seven that modify the nucleic acid backbone: hammerhead, hairpin, HDV (hepatitis delta virus), ribonuclease P, group I intron, group II intron, and VS ribozyme. The eighth type, the ribosome's peptidyl transferase center, builds peptide bonds. 2. What's all the fuss ab

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

1. What's a ribozyme? It is a catalytic RNA molecule. That discovery won the 1989 Nobel Prize in Chemistry for Tom Cech and Sidney Altman. Eight classes of ribozymes have now been identified, including seven that modify the nucleic acid backbone: hammerhead, hairpin, HDV (hepatitis delta virus), ribonuclease P, group I intron, group II intron, and VS ribozyme. The eighth type, the ribosome's peptidyl transferase center, builds peptide bonds.

2. What's all the fuss about? Two things, really. First, some researchers believe that the predecessor of the current DNA-RNA-protein world was an RNA world, in which RNA encoded both information, like DNA does, and function, as protein does. Ribozyme researchers hope to gain a glimpse of what that RNA world was like by studying ribozymes. Second, a number of researchers have had success using "in vitro evolution" to derive novel ribozyme activities.

3. Novel ribozyme activities? How do they do ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies